Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion description "[Exquisite, not infrequently fatal, sensitivity to neuroleptic drugs and encouraging reports of the effects of cholinesterase inhibitors on cognitive, psychiatric and neurological features, mean that an accurate diagnosis of DLB is more than merely of academic interest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion evidence source_evidence_literature NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion SIO_000772 12567332 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion wasDerivedFrom befree-2016 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_assertion wasGeneratedBy ECO_0000203 NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.
- befree-2016 importedOn "2016-02-19" NP382690.RAXFZFA_HcRD5xKmA1D4CNTTDSWyYYc1_Ud2P-fTsYOR8130_provenance.